Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLL4: Chlorambucil vs Fludarabine vs Fludarabine + Cyclophosphamide in CLL
NCT00004218Phase 3Completed
- Sponsor
- Blood Cancer UK
- Start
- Oct 1999
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 8
01
Overview
Phase 3, randomised trial of chlorambucil, fludarabine and cyclophosphamide in chronic lymphocytic leukemia (CLL) (5 arms), sponsored by Blood Cancer UK. Primary endpoint: Survival Rate. Started Oct 1999; status: completed.
02
Drugs
chlorambucilfludarabinecyclophosphamide
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00004218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004218.